Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,578 GBX | +0.22% |
|
+2.04% | +18.79% |
10:03am | AstraZeneca: Tagrisso approved in China for NSCLC | CF |
09:42am | AstraZeneca's Tagrisso plus chemo gets approval in China | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.79% | 25TCr | |
+55.19% | 81TCr | |
+44.96% | 65TCr | |
-6.09% | 35TCr | |
+21.92% | 34TCr | |
+3.15% | 23TCr | |
+13.73% | 22TCr | |
+10.86% | 17TCr | |
-2.78% | 16TCr | |
+0.89% | 12TCr |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Gains US FDA Approval for Endometrial Cancer Treatment